No connection

Search Results

BBAR

BEARISH
$19.38 Live
Banco BBVA Argentina S.A. · NYSE
Target $22.88 (+18.0%)
$7.76 52W Range $23.58

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$4.46B
P/E
30.28
ROE
7.2%
Profit margin
8.5%
Debt/Equity
N/A
Dividend yield
1.0%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
BBAR exhibits weak financial health with a Piotroski F-Score of just 2/9, indicating significant deterioration in fundamental performance. Despite strong long-term price appreciation, the stock trades at a premium valuation (P/E 30.28 vs sector avg 21.03) while facing sharp declines in revenue (-17.70% YoY) and earnings (-75.5% YoY). Earnings quality is poor, with 3 of the last 4 quarters missing estimates by an average of -45.13%, and key metrics like ROE (7.19%) and ROA (1.11%) remain below industry benchmarks. The lack of Altman Z-Score data raises transparency concerns, but the deterministic scorecard and deteriorating trends support a bearish outlook.

Key Strengths

Strong 5-year price performance (+853%) suggests prior investor confidence and macro tailwinds
Low analyst short interest with 4 analysts covering, indicating stable institutional attention
Dividend payout ratio is low (8.32%), providing cushion for potential yield maintenance
Current price ($19.38) is below analyst target ($22.88), implying upside potential if fundamentals stabilize
Recent 6M and 1M price gains (+22.0%, +6.0%) show short-term momentum

Key Risks

Critically low Piotroski F-Score of 2/9 signals severe financial distress and operational weakness
Revenue and earnings are in steep decline (YoY EPS -75.5%, Revenue -17.70%) with no signs of stabilization
Earnings misses have become chronic: 3 of last 4 quarters missed by over 40%, eroding credibility
High valuation despite poor growth: P/E of 30.28 is unjustifiably high relative to negative growth and sector average
Missing key financials (Debt/Equity, Cash, EV, ROIC) limits transparency and raises red flags about balance sheet health
AI Fair Value Estimate
Based on comprehensive analysis
$6.93
-64.2% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
37
Weak
Value
28
Future
25
Past
65
Health
20
Dividend
45
AI Verdict
High-risk, overvalued bank stock with deteriorating fundamentals and poor earnings quality
Key drivers: Low Piotroski F-Score (2/9), Negative earnings and revenue growth, Premium valuation despite weak fundamentals, Poor earnings surprise history, Lack of key financial disclosures
Confidence
88%
Value
28/100

Ref P/E, PEG, Graham Number

Positives
  • Analyst target price ($22.88) implies 18% upside from current levels
Watchpoints
  • P/E of 30.28 is significantly above sector average (21.03)
  • Price/Book of 5.81 is high for a regional bank with weak ROE
  • Current price ($19.38) is 180% above Graham Number ($6.93)
  • PEG unavailable due to negative growth, but implied PEG is extremely high
Future
25/100

Ref Growth rates

Positives
  • Forward P/E of 14.49 suggests earnings recovery expectations
Watchpoints
  • Revenue Growth (YoY): -17.70%
  • Q/Q Earnings Growth: -73.30%
  • Most Recent Q/Q EPS Growth: -42.9%
  • No visibility on earnings recovery given inconsistent guidance and misses
Past
65/100

Ref Historical trends

Positives
  • 5Y price return of +853% shows strong historical performance
  • Multiple quarters with large earnings beats (e.g., +216.8%, +135.7%) prior to 2024
Watchpoints
  • Recent quarters show sharp reversal in performance
  • Last 4 quarters: 3 misses, average surprise -45.13%
  • Earnings progression shows structural decline since 2024
Health
20/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • ROE of 7.19% is positive, though below cost of equity
Watchpoints
  • Piotroski F-Score of 2/9 indicates critical financial weakness
  • Missing Altman Z-Score prevents full distress risk assessment
  • No data on Debt/Equity, Current Ratio, or cash levels limits health evaluation
  • ROA of 1.11% is very low for a bank
Dividend
45/100

Ref Yield, Payout

Positives
  • Low payout ratio (8.32%) indicates dividend sustainability under current earnings
Watchpoints
  • Dividend Strength score of 25/100 reflects low yield and uncertainty
  • Dividend Yield of 1.00% is below sector average for financials
  • No 5-year yield history available, limiting trend analysis

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$19.38
Analyst Target
$22.88
Upside/Downside
+18.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BBAR and closest competitors.

Updated 2026-01-23
BBA
Banco BBVA Argentina S.A.
Primary
5Y
+853.0%
3Y
+421.2%
1Y
-15.4%
6M
+22.0%
1M
+6.0%
1W
+9.6%
IBO
International Bancshares Corporation
Peer
5Y
+73.8%
3Y
+78.8%
1Y
+28.3%
6M
+10.1%
1M
+6.9%
1W
+5.8%
TCB
Texas Capital Bancshares, Inc.
Peer
5Y
+48.7%
3Y
+101.6%
1Y
+45.3%
6M
+16.0%
1M
+4.2%
1W
-5.2%
AB
AllianceBernstein Holding L.P.
Peer
5Y
+61.4%
3Y
+31.7%
1Y
+5.9%
6M
-5.4%
1M
-0.1%
1W
-3.0%
SLM
SLM Corporation
Peer
5Y
+36.9%
3Y
+71.5%
1Y
-12.1%
6M
-11.4%
1M
+16.1%
1W
+5.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
30.28
Forward P/E
14.49
PEG Ratio
N/A
P/B Ratio
5.81
P/S Ratio
0.0
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$4.46B

Profitability

Profit margins and return metrics

Profit Margin 8.5%
Operating Margin 8.78%
Gross Margin N/A
ROE 7.19%
ROA 1.11%

Growth

Revenue and earnings growth rates

Revenue Growth -17.7%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth -73.3%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Quarterly Earnings History

EPS performance vs analyst estimates

2026-03-04
$N/A
2025-11-25
$0.12
-40.4% surprise
2025-08-20
$0.21
-43.6% surprise
2025-05-21
$0.34
-51.4% surprise

Financial Services Sector Comparison

Comparing BBAR against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
30.28
This Stock
vs
36.01
Sector Avg
-15.9% (Discount)
Return on Equity (ROE)
7.19%
This Stock
vs
-0.73%
Sector Avg
-1081.6% (Below Avg)
Profit Margin
8.5%
This Stock
vs
91.62%
Sector Avg
-90.7% (Weaker)
Revenue Growth
-17.7%
This Stock
vs
35.27%
Sector Avg
-150.2% (Slower)

Similar Companies

Peer comparison within the same industry

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
4 analysts
UBS
2025-11-19
init
Neutral
Citigroup
2025-11-03
up
Neutral Buy
HSBC
2025-10-01
up
Hold Buy
Citigroup
2025-09-11
down
Buy Neutral

Past News Coverage

Recent headlines mentioning BBAR from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile